Tramadol reduces pain by less than one point on a 10-point scale while doubling serious health risks, making safer alternatives worth considering first.
Effective pain management without risks requires discipline and actions such as those recommended by Dr. Mercola. It may be helpful to include physical therapy, exercise, psychological therapy, injections at specific points, transcutaneous electrical nerve stimulation (TENS), and lifestyle changes to improve functionality and quality of life.
Alternatives to medication:
----Physical Therapy and Exercise: Activities such as walking or guided exercises can be more effective than rest for lower back pain.
----Physical Techniques: Application of heat/cold, massage, chiropractic, or osteopathic manipulation.
----Neuromodulation: Electrical stimulation to alter how nerves process pain.
----Psychological Approach: Cognitive behavioral therapy (CBT) to change the perception of and response to pain.
----Complementary Therapies: Acupuncture, meditation, yoga, or Reiki can help improve well-being.
--------------------
Tramadol, a weak μ-opioid receptor agonist, has been used worldwide for pain management. It is considered to have a favorable safety profile without serious adverse events; however, safety issues of respiratory depression were proposed by regulatory governments. We aimed to examine the risk and contributing factors associated with tramadol-related respiratory depression using a real-world database, VigiBase. Disproportionality analysis of tramadol and tramadol/paracetamol was performed using proportional reporting ratios, reporting odds ratios, and information components for all drugs and opioids. Factors related to respiratory depression, including sex, age, presence of abuse, death, and various concomitant medications, were evaluated. Among 140,721 tramadol reports, respiratory depression was reported in 1126 cases, 81.3% of which were deemed serious. Five adverse events were detected as signals of tramadol-related acute central respiratory depression (ACRD) in 882 reports. A higher proportion of ACRD cases in children and adolescents was observed than all adverse events cases of tramadol. Concomitant users of CYP2D6 inhibitors, opioids, benzodiazepines, and anti-depressant drugs showed a higher proportion in ACRD cases than non-ACRD cases. ACRD was related to drug abuse and death. This pharmacovigilance study, using VigiBase, confirmed a high risk of respiratory depression (a serious, potentially fatal adverse event) secondary to the use of tramadol, especially in pediatric patients, drug abusers, or during concomitant use of opioids, benzodiazepines, or antidepressants.
The review found that tramadol is associated with a range of psychological symptoms, including manic episodes, hypomania, serotonin syndrome, psychosis, and cognitive impairment. Risk factors included age, pre-existing psychiatric conditions, polydrug use, and prolonged tramadol use. Elderly individuals and those with psychiatric histories were particularly vulnerable.
If the memory is working, wasn't it reported the family/owners of the original opioid touted as being safe and effective, heavily marketed and pushed as nonaddictive; Yet had indeed created a nonadditive pain killer, then patented to promptly buried it so as not to interfere with their addictive product? If so, would it be possible in the interest of public health to have it unsealed for use. If nothing else released for use for those injured in military service so as to not have addiction added to their list of injuries?
Tramadol makes me feel weird. Mentally altered.
Effective pain management without risks requires discipline and actions such as those recommended by Dr. Mercola. It may be helpful to include physical therapy, exercise, psychological therapy, injections at specific points, transcutaneous electrical nerve stimulation (TENS), and lifestyle changes to improve functionality and quality of life.
Alternatives to medication:
----Physical Therapy and Exercise: Activities such as walking or guided exercises can be more effective than rest for lower back pain.
----Physical Techniques: Application of heat/cold, massage, chiropractic, or osteopathic manipulation.
----Neuromodulation: Electrical stimulation to alter how nerves process pain.
----Psychological Approach: Cognitive behavioral therapy (CBT) to change the perception of and response to pain.
----Complementary Therapies: Acupuncture, meditation, yoga, or Reiki can help improve well-being.
--------------------
Tramadol, a weak μ-opioid receptor agonist, has been used worldwide for pain management. It is considered to have a favorable safety profile without serious adverse events; however, safety issues of respiratory depression were proposed by regulatory governments. We aimed to examine the risk and contributing factors associated with tramadol-related respiratory depression using a real-world database, VigiBase. Disproportionality analysis of tramadol and tramadol/paracetamol was performed using proportional reporting ratios, reporting odds ratios, and information components for all drugs and opioids. Factors related to respiratory depression, including sex, age, presence of abuse, death, and various concomitant medications, were evaluated. Among 140,721 tramadol reports, respiratory depression was reported in 1126 cases, 81.3% of which were deemed serious. Five adverse events were detected as signals of tramadol-related acute central respiratory depression (ACRD) in 882 reports. A higher proportion of ACRD cases in children and adolescents was observed than all adverse events cases of tramadol. Concomitant users of CYP2D6 inhibitors, opioids, benzodiazepines, and anti-depressant drugs showed a higher proportion in ACRD cases than non-ACRD cases. ACRD was related to drug abuse and death. This pharmacovigilance study, using VigiBase, confirmed a high risk of respiratory depression (a serious, potentially fatal adverse event) secondary to the use of tramadol, especially in pediatric patients, drug abusers, or during concomitant use of opioids, benzodiazepines, or antidepressants.
https://www.mdpi.com/1424-8247/17/2/205 (2025).--
The review found that tramadol is associated with a range of psychological symptoms, including manic episodes, hypomania, serotonin syndrome, psychosis, and cognitive impairment. Risk factors included age, pre-existing psychiatric conditions, polydrug use, and prolonged tramadol use. Elderly individuals and those with psychiatric histories were particularly vulnerable.
https://journals.sagepub.com/doi/abs/10.1177/00912174251322356 (2025).--
Could not agree more with these alternative pain management stratigies...
If the memory is working, wasn't it reported the family/owners of the original opioid touted as being safe and effective, heavily marketed and pushed as nonaddictive; Yet had indeed created a nonadditive pain killer, then patented to promptly buried it so as not to interfere with their addictive product? If so, would it be possible in the interest of public health to have it unsealed for use. If nothing else released for use for those injured in military service so as to not have addiction added to their list of injuries?
No opiods until it is life-or-death scenario.
I love the new format! Keep it!